Trials / Unknown
UnknownNCT03734874
The Effects of Hesperidin on Metabolic Syndrome
Evaluation of the Effects of Hesperidin Supplementation in Patients With Metabolic Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the effects of Hesperidin supplement in patients with metabolic syndrome, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | hesperidin | 500 mg hesperidin as two capsuls |
| OTHER | control | no supplementation |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2018-11-01
- Completion
- 2018-12-01
- First posted
- 2018-11-08
- Last updated
- 2018-11-08
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03734874. Inclusion in this directory is not an endorsement.